Menu Back toIs-It-Time-to-Change-the-Content-and-Format-of-Labeling

DIA 2018 Global Annual Meeting

Is It Time to Change the Content and Format of Labeling?

    Session Chair(s)
      Ingrid Stahl Bryzinski, MS, RPh

      Ingrid Stahl Bryzinski, MS, RPh

      • Senior Director, Global Labeling
      • AbbVie, United States
    How do you make labeling useful to patients and healthcare providers (HCPs) using the latest technology? This interactive panel session will include an FDA speaker, a patient representative, and an industry speaker, who will each provide insights into ensuring product labeling is useful and informative.
    Learning Objective : Identify new requirements for labeling content and format; Discuss opportunities for future enhancements to labeling to improve utility for patients and healthcare providers.
      Representative Invited

      FDA Perspective

      Representative Invited

      • FDA, United States
      Jeff  Allen, PhD

      Patient Perspective

      Jeff Allen, PhD

      • President and Chief Executive Officer
      • Friends of Cancer Research, United States